Polyphor (Switzerland)

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 10 of 19 papers

  • Discussion
  • Citations1

Imiquimod 5% for lentigo maligna of the head, neck and face: A systematic review and meta-analysis.

  • May 01, 2026
  • Journal of the European Academy of Dermatology and Venereology : JEADV
  • Laura Ghanem +9
  • Research Article

Tuning Molecular Assembly and Optical Properties via Cocrystallization: A Case Study of Roseolumiflavin in Binary and Ternary Multicomponent Systems

  • Nov 25, 2025
  • Crystal Growth & Design
  • Takin Haj Hassani Sohi +6
  • Research Article

Is Simplified Meal Announcement an Alternative to Exact Carbohydrate Counting in Patients With Type-1 Diabetes Using an Advanced Hybrid Closed-Loop System? A Systematic Review and Meta-Analysis.

  • Jul 08, 2025
  • Journal of diabetes science and technology
  • Cristina Sicorschi Gutu +6
  • Open Access
  • Research Article
  • Citations7

Spatial and Temporal Visualization of Polymorphic Transformations in Pharmaceutical Tablets.

  • Dec 02, 2024
  • Angewandte Chemie (International ed. in English)
  • Julia Gasol-Cardona +9
  • Abstract
  • Citations5

359TiP International phase III trial: Balixafortide (a CXCR4 antagonist) + eribulin versus eribulin alone in patients with HER2-negative, locally recurrent or metastatic breast cancer (FORTRESS)

  • Sep 01, 2020
  • Annals of Oncology
  • P.a Kaufman +12
  • Open Access
  • Research Article
  • Citations31

Formyl Peptide Receptor-1 Blockade Prevents Receptor Regulation by Mitochondrial Danger-Associated Molecular Patterns and Preserves Neutrophil Function After Trauma.

  • Feb 01, 2020
  • Critical Care Medicine
  • Kiyoshi Itagaki +16
  • Open Access
  • Research Article

Abstract 2007: Validation of a preclinical model for bone metastatic triple negative breast cancer

  • Jul 01, 2019
  • Cancer Research
  • Justyna Zdrojewska +5
  • Open Access
  • Research Article
  • Citations121

C-X-C Motif Chemokine Receptor 4 Blockade Promotes Tissue Repair After Myocardial Infarction by Enhancing Regulatory T Cell Mobilization and Immune-Regulatory Function.

  • Jan 31, 2019
  • Circulation
  • Yong Wang +13
  • Open Access
  • Abstract

285PD - Balixafortide (a novel CXCR4 inhibitor) and eribulin in HER2-neg metastatic breast cancer (MBC) patients (pts): A phase I trial

  • Oct 01, 2018
  • Annals of Oncology
  • J Cortés Castán +19
  • Research Article
  • Citations141

Murepavadin: a new antibiotic class in the pipeline

  • Feb 21, 2018
  • Expert Review of Anti-infective Therapy
  • Ignacio Martin-Loeches +2
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.